Emavusertib Mesylate - CAS 2376399-40-3

Emavusertib Mesylate (also known as CA-4948) is a potent inhibitor of IRAK4 and FLT3, demonstrating antitumor activity. In cell lines of ABC DLBCL and AML, CA-4948 shows significant cellular activity. Moreover, it exhibits moderate to high selectivity in screening assays of 329 kinases and has impressive pharmacokinetic and pharmacodynamic profiles (ADME and PK), with good oral bioavailability in mice, rats, and dogs. In pertinent tumor models, CA-4948 achieves over 90% tumor growth inhibition and shows excellent correlation with in vivo PD modulation.

MyD88, NF-κB, IRAK, FLT, Apoptosis

Apoptosis, Immunology/Inflammation, NF-κB, Tyrosine Kinase/Adaptors, Angiogenesis

2376356

C25H29N7O8S

587.61

S(C)(=O)(=O)O.N(C(=O)C=1N=C(OC1)C=2C=C(C)N=CC2)C3=C(N=C4C(=C3)OC(=N4)N5CCOCC5)N6CC[C@@H](O)C6

-20°C

Ice Packs

Small Compound